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The family of mammalian Sirtuin proteins com-
prises seven members homologous to yeast
Sir2. Here we show that SIRT2, a cytoplasmic
sirtuin, is the most abundant sirtuin in adipo-
cytes. Sirt2 expression is downregulated during
preadipocyte differentiation in 3T3-L1 cells.
OverexpressionofSIRT2 inhibits differentiation,
whereas reducing SIRT2 expression promotes
adipogenesis. Both effects are accompanied
by corresponding changes in the expression of
PPARg, C/EBPa, and genes marking terminal
adipocyte differentiation, including Glut4, aP2,
and fatty acid synthase. The mechanism under-
lying the effects of reduced SIRT2 in 3T3-L1
adipocytes includes increased acetylation of
FOXO1, with direct interaction between SIRT2
and FOXO1. This interaction enhances insulin-
stimulated phosphorylation of FOXO1, which
in turn regulates FOXO1 nuclear and cytosolic
localization. Thus, Sirt2 acts as an important
regulator of adipocyte differentiation through
modulation of FOXO1 acetylation/phosphoryla-
tion and activity and may play a role in control-
ling adipose tissue mass and function.
INTRODUCTION
The SIR2 (silent information regulator 2) proteins belong to
the family of class III NAD-dependent deacetylases that
catalyze a reaction in which NAD and an acetylated
substrate are converted into a deacetylated protein, nico-
tinamide, and a novel metabolite O-acetyl ADP-ribose
(Tanner et al., 2000). The founding member of the family,
sir2, was originally discovered in yeast as a factor that
silences the mating-type locus (Imai et al., 2000; Tanny
et al., 1999). sir2 is also involved in telomere regulation,
maintenance of genomic integrity, and lifespan extension
in yeast, and similar effects have been shown for its ortho-
log inC. elegans (Imai et al., 2000; Wang and Tissenbaum,
2006).
In mammals, the homologs of sir2 have been named sir-
tuins (sirt), with seven members in a family termed sirt1
through sirt7. They share a conserved central deacetylaseCelldomain but have different N- and C termini and display
distinct subcellular localization, suggesting different bio-
logical functions (North and Verdin, 2004). Mammalian
sirt1 is most homologous to yeast sir2 and is found pre-
dominantly in the nucleus, consistent with its roles in for-
mation of heterochromatin and gene silencing by histone
deacetylation. In mammalian cells, instead of genome si-
lencing, sirt1 often promotes gene transcription by deace-
tylating specific transcription factors, corepressors, and
coactivators, including p53, PGC-1a, NF-kB, MyoD, and
members of the FOXO family (Daitoku et al., 2004; Fulco
et al., 2003; Luo et al., 2001; Nemoto et al., 2005; Yeung
et al., 2004). In adipocytes, sirt1 acts as an inhibitor of adi-
pogenesis by interacting with PPARg corepressor NcoR
and SMART, thereby repressing PPARg activity (Picard
et al., 2004).
Much less is known about the function of the other sir-
tuins. In contrast to SIRT1, mammalian SIRT2 is localized
mainly in the cytoplasm. Studies in mammalian cells have
suggested that sirt2may play a role in cell cycle regulation
and be involved in cytoskeleton organization by targeting
the cytoskeletal protein tubulin (North et al., 2003). The
yeast ortholog of sirt2, hst2, has been shown to extend
lifespan by a mechanism independent of sir2/hst1 (Lam-
ming et al., 2005). Functional studies showed that sirt3 de-
acetylates acetyl-CoA synthase 2 (ACS2) and regulates its
activity (Hallows et al., 2006; Schwer et al., 2006). The sirt3
also appears to be involved in longevity (Rose et al., 2003).
The functions of sirt4–7 are less clear; recent reports have
shown that sirt6 may also be involved in aging in mice,
while sirt7 appears to regulate DNA pol I transcription
(Ford et al., 2006; Mostoslavsky et al., 2006).
Mammalian forkhead transcription factors of class O
(FoxO) include foxO1, foxO3a, and foxO4 and have been
shown to be involved with wide range of cellular pro-
cesses, such asDNA repair, cell cycle control, stress resis-
tance, apoptosis, and metabolism (Barthel et al., 2005;
Furukawa-Hibi et al., 2005). Among all FoxO members,
foxo1appears tohavean important role in adipocyte differ-
entiation, acting as an inhibitor of adipogenesis at an early
phase of the differentiation process (Nakae et al., 2003).
In this context, the enzyme phosphatidylinositol 3-kinase
(PI-kinase), which is stimulated by insulin and certain cyto-
kines and growth factors, can negatively regulate FoxOs
(Zhang et al., 2002). This inhibitory effect of insulin ismainly
mediated by Akt/PKB phosphorylation of FOXO, which
promotes the trafficking of FOXO from the nucleus to the
cytosol. The transcriptional activity of FOXO proteins canMetabolism 6, 105–114, August 2007 ª2007 Elsevier Inc. 105
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can be acetylated by CBP acetyl-transferase, and SIRT1
has been shown to deacetylate FOXO1 and regulate its
activity, especially under conditions of stress (Matsuzaki
et al., 2005; van der Heide and Smidt, 2005). Recently, it
has been shown that the extent of deacetylation of FOXO1
can affect its phosphorylation and DNA binding activity to
target gene promoters (Matsuzaki et al., 2005).
In the present study, we demonstrate that sirt2mRNA is
more abundant than other sirtuins in adipocytes in vivo
and in culture and that sirt2 exerts an inhibitory effect on
adipocyte differentiation. This is mediated by regulating
FOXO1 deacetylation, leading to changes in FOXO1 phos-
phorylation, increased nuclear localization, and inhibition
of adipogenesis. Thus, activators of sirt2 could provide
novel therapeutics of obesity and its complications.
RESULTS
Sirt Isoforms’ Expression during Adipocyte
Differentiation of 3T3-L1 Cells
Various isoforms of mammalian Sirt proteins are ex-
pressed in adipose tissue and 3T3-L1 preadipocytes,
with varying expression patterns during differentiation.
Affymetrix microarrays that were performed on isolated
adipocytes indicated that sirt1, sirt2, and sirt3 were all ex-
pressed in adipocytes and that the level of sirt2was much
higher than that of sirt1 or sirt3 (Figure 1A, top panel).
Using quantitative real-time PCR with cDNA standard
curves for each isoform as described in Experimental Pro-
cedures, the molar amounts of different Sirt transcripts
per microgram of total RNA were obtained. As shown in
Figure 1A (lower panel), the molar amount of sirt2 mRNA
per microgram total RNA in 3T3-L1 preadipocytes was
4–53 that of sirt1 and 6–73 that of sirt3. Similar studies in-
cluding other sirtmembers confirmed that sirt2 transcripts
are more abundant than others (Figure S1). During the first
2 days of differentiation (i.e., the induction phase), levels of
both sirt1 and sirt2 mRNA decreased by 60%–70% and
then remained stable for the remainder of the time course
of differentiation (Figure 1B, top and middle panels). Sirt3
mRNA on the other hand, started at a low level compared
to both sirt2 and sirt1, then increased by 3- to 4-fold during
adipocyte differentiation (Figure 1B, bottom panel).
Effects of sirt2 Knockdown and Overexpression
in 3T3-L1 Adipocytes
To investigate the potential role of sirt2 in preadipocytes,
we used retroviruses to generate 3T3-L1 stable cell lines
carrying either shRNAs targeting endogenous sirt2 or GFP
as a control. Since there was no good antibody available
for mouse SIRT2 at the time these experiments were pre-
formed, we used real-time PCR to assess sirt2 mRNA
levels. This revealed that, compared with shGFP cells,
cells stably expressing the two shsirt2 retroviruses ex-
hibited an 80%–90% knockdown of sirt2 mRNA, with no
significant change in the level of sirt1 or sirt3mRNAs (Fig-
ure 1C). Furthermore, when the same two retroviral con-
structs were transiently cotransfected into HEK293 with106 Cell Metabolism 6, 105–114, August 2007 ª2007 Elsevier Ina CMV-driven SIRT2-FLAG construct, there was a parallel
80%–90% reduction of the tagged SIRT2 protein when
compared with cells cotransfected with shGFP (Fig-
ure 1D). Thus, the expression of both shsirt2 constructs
produced major reductions of sirt2 at the RNA and protein
levels, and this reduction was specific to the sirt2 isoform.
Later commercial availability of SIRT2 antibody allowed us
to detect a similar decrease of endogenous SIRT2 protein
in shsirt2 cells (Figure 1D).
Preadipocytes stably transfected with either shsirt2 or
shGFP were then subjected to adipogenic differentiation
Figure 1. Expression of sirt2 and Stable sirt2 Knockdown in
3T3-L1 Preadipocytes
(A) Affymetrixmicroarray analysis was performed usingmRNA isolated
from epididymal adipocytes as described previously (Gesta et al.,
2006). To confirm these findings, quantitative real-time PCR was
performed as described in Experimental Procedures.
(B) Using real-time PCR, changes in expression of the different Sirt
mRNA were assessed during 3T3-L1 white adipocyte differentiation.
sirt2 mRNA was the most abundant in adipocytes, and both Sirt1
and sirt2 had a similar pattern of diminishing expression during adipo-
cyte differentiation.
(C) shRNA overexpression constructs were generated with pSuper-
Retro vector. Two shRNA constructs (S-1 and S-2) were tested by
targeting different exons of sirt2 genomic sequence. An shGFP RNAi
sequence was used as control. After retroviral infection and selection,
3T3-L1 preadipocytes carrying either shGFP or shsirt2 overexpression
constructs were grown to confluence, then RNA was extracted to
synthesize cDNA, and real-time PCR was performed for Sirt1–3.
(D) Transient transfection experiments were done using two different
shRNA and control shRNA constructs along with either control pBabe
or Sirt2-FLAG overexpression. Both shsirt2 (S1 and S2) effectively
knock down the overexpression of SIRT2-FLAG protein. Endogenous
sirt2 knockdown was also detected by western blot. All the error bars
in this figure refer to standard error (SE) of the mean.c.
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Role of SIRT2 in Adipocyte Differentiationprotocol, and samples from different time points were col-
lected for either RNA or protein analysis. Oil Red O stain-
ing during the time course of differentiation confirmed the
increased rate and extent of differentiation, with increased
staining of cells by day 4 indicating more rapid accumula-
tion of lipid in sirt2 knockdown cells (Figure 2A). As noted
above, in control shGFP-expressing cells sirt2 mRNA
expression decreased during the time course of differen-
tiation, while in the shsirt2 -expressing cells, endogenous
sirt2mRNA as assessed by real-time PCRwas reduced by
75%–80%, and this persisted throughout the time course
of adipocyte differentiation (Figure 2B). As expected, sirt2
knockdown had no significant effect on levels of Sirt1
mRNA or on the change in Sirt1 that occurred during dif-
ferentiation, consistent with the specificity of sirt2 knock-
down (Figure 2B). By contrast, in the sirt2 knockdown
cells, two transcription factors central to adipogenic dif-
ferentiation, C/EBPa and PPARg, both demonstrated sig-
nificantly accelerated and exaggerated increase in mRNA
expression. Thus, C/EBPamRNA level was elevatedmore
than 3-fold in shsirt2 cells on day 2 after induction com-
pared with control cells (p = 0.001), and this difference
remained throughout the time course of differentiation
(Figure 2B). PPARg mRNA levels in shsirt2 cells were
also 2- to 3-fold higher than in shGFP cells after induction
and throughout the time course, with the greatest increase
on day 2 (Figure 2B). Corresponding to elevated early
adipogenic transcription factor expression, mRNA levels
of various late adipocyte differentiation markers that are
downstream C/EBPa and PPARg (Lane et al., 1999; Qi
et al., 2000) were also significantly enhanced in shsirt2
cells during the time course of differentiation. For exam-
ple, on day 2 after induction, shsirt2 cells had 3-fold
higher levels of aP2 mRNA (p = 0.002) and 2-fold higher
levels of fatty acid synthase (FAS; p = 0.0014) and Glut 4
mRNA (p = 0.0055) when compared to control cells (Fig-
ure 2B). On the other hand, expression of foxo1 showed
no significant change at mRNA level at any time point
during differentiation (Figure 2B).
Western blot analysis of proteins confirmed these
effects of sirt2 knockdown on expression of adipocyte
differentiation markers (Figure 2C). On day 2 after induc-
tion, there was a 2-fold increase in C/EBPb and a 5-fold
increase in C/EBPa protein in shsirt2 cells compared to
control, and this increase in C/EBPa persisted through dif-
ferentiation, even as levels in the control cells increased.
A similar pattern of increased protein expression was ob-
served for PPARg protein in shsirt2 cells. The increase
was even more marked for the late adipocyte differentia-
tion marker, FAS, which was 4-fold elevated at the protein
level in shsirt2 cells on day 2 compared to controls, al-
though this difference diminished on day 8 as the cells be-
came mature and FAS expression increased in the control
cells (Figure 2C). Endogenous SIRT2 protein expression
was consistent with its mRNA expression during differen-
tiation in shGFP cells, while endogenous SIRT2 protein
was knocked down in shsirt2 cells.
Opposite effects were observed in 3T3-L1 cells overex-
pressing sirt2. Overexpression of SIRT2-FLAG in 3T3-L1Cellcells inhibited adipocyte differentiation and lipid accumu-
lationcomparedwithemptyvectorcontrol cells (Figure3A).
Western blot analysis of adipocyte markers, such as
PPARg and FAS, also revealed decreased levels in sirt2-
overexpressing cell line (Figure 3A). As insulin signaling
pathway is one of the major pathways that controls adipo-
genesis and adipocyte differentiation, we tested if the
effect of sirt2 on 3T3-L1 differentiation was due to altered
insulin signaling. Acute (10 min) insulin stimulation of both
control and sirt2-overexpressing cell lines produced equal
phosphorylation responses for Akt, p42/p44 MAP kinase,
and p38 MAP kinase (Figure 3B). Thus, overexpression of
sirt2 in 3T3-L1 cells inhibits the normal adipogenic pro-
cess, and this effect occurs without a change in upstream
Figure 2. Sirt2KnockdownPromotes 3T3L1 Adipocyte Differ-
entiation
(A) Stable shRNA-transfected 3T3-L1 preadipocytes were subjected
to differentiation using the standard protocol. Oil Red O staining of
shGFP and shsirt2 cells on day 4 of differentiation indicated that shsirt2
had accelerated differentiation with enhanced lipid staining.
(B) During 3T3-L1 adipocyte differentiation, shsirt2 cells (empty circles)
had consistently lower endogenous sirt2mRNA expression compared
with shGFP cells (solid circles). The mRNA expression for various dif-
ferentiation markers was also determined by real-time PCR.
(C) The protein expression of different adipocyte differentiation
markers was determined by western blotting. All the error bars in this
figure refer to SE of the mean.Metabolism 6, 105–114, August 2007 ª2007 Elsevier Inc. 107
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hances the programof adipogenic gene expressions at the
mRNA and protein levels, and this is associated with en-
hanced lipid accumulation. The subcellular localization of
SIRT2-FLAG overexpression is similar to previous reports
that SIRT2 is mainly a cytoplasmic protein (Figure S2).
SIRT2 Interacts with and Deacetylates FOXO1
in 3T3-L1 Preadipocytes
Foxo1, a known inhibitor of adipogenesis, has been pre-
viously shown to undergo regulated acetylation and
deacetylation (Matsuzaki et al., 2005; Perrot and Rechler,
2005; Daitoku et al., 2004). Since there was no change
in foxo1 expression at the mRNA level, we explored
whether FOXO1 protein expression or acetylation might
be changed. Immunoprecipitation using anti-acetyl-Lys
antibody followed by blotting with anti-FOXO1 antibody
revealed that in control shGFP cells, most of the FOXO1
protein was in a deacetylated state (i.e., FOXO1 could
not be detected in precipitated total acetylated protein).
By contrast, in the Sirt2 knockdown cells, FOXO1 acetyla-
tion was markedly increased, and the anti-FOXO1 anti-
body easily detected the presence of FOXO1 protein in
Figure 3. Sirt2 Overexpression Inhibits 3T3-L1 Adipocyte
Differentiation without Affecting Insulin Signaling in Preadi-
pocytes
(A) Following the differentiation protocol described in Experimental
Procedures, Oil Red O staining of stably transfected 3T3-L1 cells with
either control pBabe vector or SIRT2-FLAG-pBabe overexpression
construct showed that exogenous Sirt2 overexpression inhibited
adipocyte differentiation as compared with control cells.
(B) Insulin signaling was assessed by western blotting of phospho-Akt,
phospho-p38, and phospho-MAP kinase in confluent 3T3L1 preadipo-
cytes. Stimulation was performed using 10 and 100 nM insulin for
5 min.108 Cell Metabolism 6, 105–114, August 2007 ª2007 Elsevier Inthe precipitated lysate (Figure 4). This effect was specific
because western blot analysis with anti-FoxO3a antibody
did not detect any increased protein acetylation (data not
shown). To verify the increased FOXO1 acetylation in Sirt2
knockdown cells, the IP of exogenous FOXO1-FLAG pro-
tein was donewith both shGFP and shsirt2 cell lysates; the
results indicate that while a similar amount of FOXO1-
FLAG protein is precipitated from either cell line, there is
increased acetylation on FOXO-FLAG precipitated from
shsirt2 cell lysate (Figure S3). These effects on FOXO1
acetylation occurred with no change in the total level of
FOXO1 protein in sirt2 knockdown cells and no change
in the level of Sirt1 protein (Figure 4), another member of
the Sirt family, which is able to deacetylate FoxOs.
The increased acetylation on FOXO1 in sirt2 knockdown
cells indicates that foxo1 can serve as a potential target for
SIRT2 deacetylase activity. To investigate if SIRT2 inter-
acts with FOXO1 directly, we performed immunoprecipi-
tation of total cell lysates of cells overexpressing SIRT2-
FLAG versus control cells infected with the empty pBabe
retrovirus using a monoclonal anti-FLAG antibody con-
jugated to agarose. The immunoprecipitates were then
immunoblotted with anti-FOXO1 antibody. In the cells ex-
pressing the SIRT2-FLAG construct, the anti-FLAG anti-
bodycoprecipitatedsignificantlymoreFOXO1protein than
in control cells (Figure 5A), indicating that SIRT2 is present
in a complex with FOXO1 protein. Western blot analysis of
the same cell lysates with anti-FOXO1 antibody showed
that this occurredwith no difference in total FOXO1protein
content between SIRT2-FLAG and control cell lines (Fig-
ure 5A). The unchanged FOXO1 protein levels in preadipo-
cytes of both sirt2 knockdown and -overexpressing cells
is consistent with the real-time PCR data indicating that
foxo1 mRNA expression was not altered in sirt2 knock-
down cells during 3T3-L1 differentiation (Figure 2B). In ly-
sates from cells overexpressing recombinant SIRT2-HA
and FOXO1-FLAG, SIRT2-HA can coimmunoprecipitate
Figure 4. Sirt2 Knockdown Promotes FOXO1 Acetylation
Nondenaturing total protein extracts from either shGFP or shsirt2 cells
were immunoprecipitated with anti-acetylated-Lys antibody, and pre-
cipitated lysates were blotted with anti-Foxo1 antibody. Total lysate
input was detected by western blotting.c.
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tion between SIRT2 and FOXO1 protein.
Acetylation of FOXO1 Regulates Its Phosphorylation
and Adipocyte Differentiation in 3T3-L1 Cells
To determine if the increased acetylation of FOXO1 could
alter its ability to undergo phosphorylation, we treated
Figure 5. SIRT2 Interacts with FoxO1 In Vitro and sirt2Knock-
down Promotes FoxO1 Phosphorylation and Cytosolic Local-
ization
(A) The nondenaturing lysates from either pBabe control or SIRT2-
FLAG overexpression cell lines were immunoprecipitated with anti-
FLAG-agarose. The precipitated lysates were blotted with anti-FOXO1
antibody. Markedly more FOXO1 protein was precipitated with anti-
FLAG-agarose from SIRT2-FLAG-overexpressing cells.
(B) The nondenaturing lysates from HEK293 cells transiently trans-
fected with SIRT2-HA- and/or FOXO1-FLAG-overexpressing con-
structs were subjected to immunoprecipitation with anti-HA agarose.
Western blot of protein eluted from HA-agarose shows that there is
interaction between SIRT2 and FOXO1 in vitro.
(C) The shGFP or shsirt2 cells were acutely (5 or 15min) stimulated with
different concentrations of insulin (10 and 100 nM) after serum depriva-
tion. Insulin-stimulated Akt and GSK3b phosphorylation (5 min stimu-
lation) as well as FOXO1 phosphorylation (15 min stimulation) were
assessed by western blotting.
(D) Following a modified protocol for cytosolic and nuclear extract de-
scribed previously (Emanuelli et al., 2000), lysates from both shGFP
and shsirt2 cells were subjected to western blot analysis with anti-
FOXO1 antibody. There was more FOXO1 protein translocated to the
cytosol in shSirt2 3T3L1 cells. SOD4 and LaminA (LmnA) bands
showed effective separation of nuclear and cytosolic proteins. Immu-
nocytochemistry was done with cells carrying FoxO1-FLAG-overex-
pressing construct with either stably transfected shGFP or shsirt2.
Cells were fixed 48 hr after being plated in 10% FBS DMEM media.
The anti-FLAG-FITC was used to detect subcellular localization of
the recombinant FOXO1 in the cells.Celserum-deprived shsirt2 and shGFP preadipocytes with in-
sulin at different concentrations and immunoblotted cell
extracts with an antibody that detects phosphorylation of
FOXO1 Ser-253, the major site of FOXO1 phosphorylation
by Akt/PKB (van der Heide et al., 2004). Consistent with
the data above, insulin stimulated Akt/PKB phosphoryla-
tion to the same level in the sirt2 knockdown and control
cell lines. On the other hand, phosphorylation of FOXO1
on Ser-253 was increased 2-fold in the sirt2 knockdown
cell line (Figure 5C). Since phosphorylation is known to af-
fect nuclear translocation, nuclear and cytosolic extracts
from shGFP and shsirt2 cells were prepared and sub-
jected to immunoblot analysis with anti-FOXO1 antibody.
This revealed a 2- to 3-fold increase in the level of cyto-
solic FOXO1 protein in Sirt2 knockdown cells. Also, it was
clear that the cytosolic FOXO1 band migrated in a slightly
retarded position on the gel in the shsirt2 cells, consistent
with increased FOXO1 phosphorylation, whereas the nu-
clear FOXO1 protein migrated at a lower position on the
gels due to its unphosphorylated state. Furthermore, nu-
clear FOXO1was decreased in amount (Figure 5D). Due to
high background of FOXO1 antibody, we generated 3T3
L1 cell lines overexpressing FLAG-tagged FOXO1 along
with either shGFP or shsirt2 stable constructs, then used
anti-FLAG to detect the subcellular localization of re-
combinant FOXO1. FOXO1-FLAG was largely excluded
from the nucleus of cells overexpressing shsirt2, while
cells overexpressing shGFP showed a more diffusive pat-
tern of FOXO1-FLAG localization (Figure 5D). Immunoblot
of total protein lysates with anti-FOXO1 antibody revealed
no difference in total FOXO1 protein between the two lines
(Figure 5C). To validate the effect of foxo1 on adipocyte
differentiation, an shRNA-mediated endogenous foxo1
knockdown experiment was done, and the effects of
foxo1 knockdown on adipogenesis were accessed. The
results showed that reducing endogenous foxo1 expres-
sion efficiently promoted adipocyte differentiation with
increased Oil Red O staining accompanied by increased
adipocyte marker expression, such as PPARg and C/
EBPa (Figure S4).
Analysis of FOXO1 Phosphorylation Using
Acetylation Mutants
To further analyze the possible role of FOXO1 acetylation
in the regulation of FOXO1 phosphorylation, we used 3T3-
L1 cell lines overexpressing either wild-type foxo1 or two
foxo1 mutants that mimic different acetylation states of
the protein. In the KQ mutant, the three Lys residues sur-
rounding Ser-253 that are known to be sites of acetylation
were replaced by glutamine residues. In the KR mutant,
these Lys were replaced by Arg residues. All three overex-
pression constructs were generated with an N-terminal
FLAG tag to allow quantitation of the protein. Immunoblot-
ting of lysates from confluent cells overexpressing either
foxo1wild-type or the KQ and KR mutants with anti-FLAG
monoclonal antibody revealed that all three proteins were
equally overexpressed (Figure 6A). Quantitative PCR indi-
cated a 5-fold increase in total foxo1 mRNA in each line
as compared to endogenous foxo1 levels (Figure S5).l Metabolism 6, 105–114, August 2007 ª2007 Elsevier Inc. 109
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3T3-L1 Adipocyte Differentiation and FOXO1Phosphorylation
(A) Different foxo1 overexpression constructs were made with either
wild-type FOXO1 amino acid sequence or by replacing all three Lys
residues surrounding Ser-253 with Gln (KQ) or Arg (KR). The foxo1
WT, KQ, and KR overexpression constructs were all FLAG tagged.
Overexpression was determined by western blotting using anti-FLAG
antibody. Quantitative PCRwith primers targeting the foxo1 coding re-
gion showed that the level of overexpression of different constructs
was similar and was about 53 the level of endogenous foxo1 observed
in control cells (Figure S2). Cell lines carrying various foxo1 overex-
pression constructs or control cells were subjected to the differentia-
tion protocol described in Experimental Procedures. Oil RedO staining
of cells 8 days after differentiation induction showed differences
among different cell lines. Real-time PCR quantification of different
adipocyte markers was consistent with the degree of adipocyte differ-
entiation as assessed by bright light microscopic image and Oil Red
O staining. Cells overexpressing wild-type foxo1 had significantly
decreased mRNA expression of different adipocyte differentiation
markers compared with control cells, as indicated with ‘‘a,’’ while cells
expressing the KR mutant had significantly decreased mRNA expres-
sion compared with that of wild-type foxo1 overexpression, as indi-
cated with ‘‘b.’’
(B) FOXO1 mutations mimicking different Lys acetylation states affect
Ser-253 phosphorylation of FOXO1 and 3T3L1 adipocyte differentia-
tion. After serum deprivation for 12 hr, 3T3L1 cells carrying wild-type
foxo1, KQ, and KR mutant overexpression constructs were acutely
stimulated with different concentrations (10 or 100 nM) of insulin for
10 min. Total cell extracts were subjected to western blot analysis to
assess insulin-stimulated phosphorylation status of FOXO1, Akt, and
GSK3b. KQ mutant overexpression promoted both basal and insulin-
stimulated FOXO1 phosphorylation, whereas cells overexpressing
the KR mutant had decreased FOXO1 phosphorylation in response
to insulin (both as compared to cells overexpressing wild-type foxo1).
(C) Immunocytochemistry of different foxo1 wild-type and mutant
overexpressing cells was performed using anti-FLAG-FITC. Different110 Cell Metabolism 6, 105–114, August 2007 ª2007 Elsevier InQuantitative PCR using primers targeting the untranslated
region of endogenous foxo1mRNA demonstrated that the
endogenous foxo1 expression level was not affected by
expression of the exogenous protein (data not shown).
The cell lines overexpressing wild-type and mutant
foxo1were subjected to the standard adipogenic differen-
tiation protocol and stained with Oil Red O. Cells overex-
pressing wild-type foxo1 showed much less Oil Red O
staining, consistent with a significantly decreased level of
differentiation, than cells infected with the empty vector.
This finding is consistent with the known ability of foxo1
to suppress adipogenesis. The cells overexpressing the
KQmutant of foxo1, whichmimics the acetylated state, ex-
hibited enhanced differentiation comparedwith cells over-
expressingwild-type foxo1. In contrast, cells overexpress-
ing the KRmutant, whichmimics the deacetylated protein,
showed decreased differentiation compared with cells
overexpressing wild-type foxo1 (Figure 6A). These differ-
ences in lipid accumulation correlatedwell with expression
of different adipocyte differentiation markers such as aP2,
PPARg, and C/EBPa by quantitative PCR (Figure 6A).
Assessment of FOXO1 Ser-253 phosphorylation after
insulin stimulation in these cell lines revealed increased
phosphorylation of theKQmutant in thebasal state, aswell
as a substantially higher level of phosphorylation following
insulin stimulationwhen comparedwith cells overexpress-
ing wild-type protein. By contrast, cells expressing the KR
mutant of foxo1 showed decreased Ser-253 phosphoryla-
tion in the insulin-stimulated condition (Figure 6B). Thus,
the FOXO1 acetylation mimic had increased Ser-253
phosphorylation, whereas the deacetylated FOXO1mimic
had decreased Ser-253 phosphorylation. The FLAGwest-
ern blot shows that the total recombinant FOXO1 protein
expression is not altered under above conditions. These
changes on FOXO1 phosphorylation occurred with no
change in the level of phosphorylated/activated Akt and
phosphorylated GSK3b (Figure 6B). The subcellular
localization of FOXO1 mutants detected by immunocyto-
chemistry using anti-FLAG-FITC was consistent with the
observed differences in localization by subcellular frac-
tionation and FOXO1 phosphorylation. Both foxo1 wild-
type and KR overexpression had a diffused distribution
within the cell, but KQ mutant had a nuclear exclusion
pattern, where the KQ was more phosphorylated and
localized in the cytoplasm (Figure 6B).
DISCUSSION
The sirtuins represent a complex family of proteins that
show homology to the yeast class III NAD-dependent pro-
tein/histonedeacetylase sir2.Sirt1, the best-characterized
member of the family, is localizedmainly in the nucleus and
has been shown to interact with and regulate a number of
transcription factors, corepressors, and coactivators,
thereby modulating downstream biological processes.
Other Sirt proteins have different subcellular localizations,
subcellular localization patterns are observed for foxo1 mutants. All
the error bars in this figure refer to SE of the mean.c.
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activities, suggesting that their biological functions are
quite different (Liszt et al., 2005; North and Verdin, 2004).
SIRT2, for example, is localized primarily in the cytoplasm
and has deacetylase activity (Dryden et al., 2003; North
et al., 2003), but its biological functions remain largely
unknown.
In the present study, we find that sirt2 mRNA is more
abundant than other Sirts in both adipose tissue in vivo
and preadipocytes in culture, with quantitative mRNA
levels being 4–73 higher than those for sirt1 or sirt3. In ad-
dition, sirt2 and sirt1 expression is downregulated during
adipocyte differentiation, whereas sirt3 mRNA levels in-
crease. By creating 3T3-L1 cell lines with stable over-
expression and knockdown of sirt2, we find that high
levels of sirt2 expression inhibit adipocyte differentiation,
whereas reducing sirt2 levels has the opposite effect.
The promotion of adipocyte differentiation by sirt2 is as-
sociated with increased expression of C/EBPa, PPARg,
Glut4, aP2, and FASmRNAs, as well as increased expres-
sion of C/EBPb, one of the earliest transcriptional changes
in the normal program of adipocyte differentiation (Tang
et al., 2004). Thus sirt2 must act upstream of C/EBPb at
an even earlier event in induction of adipogenesis, and
this appears to be at the level of FoxO1 acetylation/phos-
phorylation. Reducing the level of sirt2 in the knockdown
cells results in an increased level of FOXO1 acetylation,
which in turn allows increased phosphorylation on Ser-
253, excluding FOXO1 from the nucleus. This allows differ-
entiation to progress, likely by reducing the ability of
FOXO1 to interact with the PPARg promoter and repress
PPARg transcription (Armoni et al., 2006). Although there
is evidence that foxo1 also acts during late-stage differen-
tiation, the effect of foxo1overexpressionondifferentiation
appears to occur prior to the induction of early differentia-
tion markers like C/EBPb/s, possibly at the level of clonal
expansion. The effect of sirt2 knockdown suggests that
SIRT2mayact on foxo1during this clonal expansion stage.
In the process of adipocyte differentiation, insulin and/
or IGF-1 act to stimulate FOXO1 phosphorylation on Ser
residues through activation of Akt. The Ser phosphoryla-
tion of FOXO1 excludes it from the nucleus (Zhang et al.,
2002), thus reducing its ability to repress PPARg transcrip-
tion. Changing the level of sirt2 alters the phosphorylation
status of FOXO1 (in this case not because of a change in
insulin/IGF-1 action on Akt, but because phosphorylation
of FOXO1 can also be regulated by acetylation/deacetyla-
tion of the Lys residues surroundingSer-253, themajor site
of regulatory phosphorylation (Zhang et al., 2002; Matsu-
zaki et al., 2005). While previous studies have suggested
that CBP can act as a FOXO1 acetyl-transferase (Matsu-
zaki et al., 2005; Perrot and Rechler, 2005), it is not clear
which enzyme deacetylates FOXO1. In the nucleus, SIRT1
has been shown to deacetylate FOXO1. This increases the
level of FOXO1 localized in the nucleus, allowing it to be
transcriptionally active (Frescas et al., 2005). In this study,
we find that FOXO1 can also be a target of the cytoplasmic
SIRT2 deacetylase and that in this context sirt2 plays a
potentially important role in adipocyte differentiation.Cell MThere are several criteria by which this effect on differ-
entiation appears to be the direct action of sirt2 rather
than an indirect effect of sirt1. First, FOXO1 acetylation is
increased by sirt2 knockdown. This effect on FOXO1 acet-
ylation is independent of changes in levels of sirt1 or
FOXO1 expression, supporting the notion that SIRT2 de-
acetylates FOXO1 rather than acting indirectly by de-
creasing Sirt1 expression level. Second, SIRT2 interacts
with FOXO1 as shown by coimmunoprecipitation experi-
ments. Third, in sirt2 knockdown cells there is increased
Ser-253 phosphorylation in response to insulin stimula-
tion, which results in nuclear exclusion of FOXO1. This re-
leases adipogenesis from foxo1 inhibition. These data are
consistent with the notion that acetylation of FOXO1 in the
cytoplasm makes it more accessible to Akt phosphoryla-
tion, in turn promoting retention of FOXO1 in the cytosol,
where it is transcriptionally inactive and thus unable to re-
press expression of genes like PPARg. In this way, in-
creased acetylation reduces the inhibitory effect of foxo1
on adipogenesis and promotes differentiation.
This role of acetylation of FOXO1 in adipogenesis is fur-
ther supported by our studies using foxo1mutants. There
are three Lys residues surrounding the Ser-253 in thewild-
type mouse FOXO1 protein. These three Lys residues can
be acetylated by the protein acetyl-transferase CBP and
deacetylated by Class III deacetylases, such as SIRT2.
Recent studies have shown that acetylation/deacetylation
of these Lys andSer phosphorylation can act in a synergis-
tic manner (Matsuzaki et al., 2005). Thus when FOXO1 is
acetylated by CBP, it is more accessible to phosphoryla-
tion, and this leads to its cytosolic translocation. In the
foxo1 KQmutant, three Lys residues surrounding Ser-253
are replaced by glutamine. Previous studies on p53 have
shown that substitution of glutamine for Lys serves to
mimic a constitutive ‘‘acetylated’’ form of the p53 (Wang
et al., 2003). On the other hand, replacing Lys with Arg,
as in the foxo1 KR mutant, serves to mimic the ‘‘deacety-
lated’’ form of protein (Feng et al., 2005; Marcotte et al.,
2004). In agreement with Matsuzaki, et al. (2005), we find
that these two foxo1mutants behave differently in terms of
acetylation and Ser-253 phosphorylation in response to
insulin stimulation when compared with wild-type foxo1.
Thus, overexpression of the KR mutant, which is acetyla-
tion resistant, inhibits 3T3-L1 differentiation to an even
greater extent than wild-type foxo1, whereas overexpres-
sion of the KQmutant that mimics acetylated FOXO1 pro-
motes differentiation. In each case, this correlates with
the Ser phosphorylation of the FOXO1 protein. Cells over-
expressing WT FOXO1 exhibit an increased level of Ser-
253 phosphorylation following insulin activation of Akt,
while cells expressing the KQ mutant have higher levels
of FOXO1 phosphorylation with or without any insulin
stimulation. Cells overexpressing the KR mutant demon-
strate the opposite with reduced FOXO1 phosphorylation
following insulin stimulation. Since all these occur with the
same level of Akt and GSK3b phosphorylation/activation,
these findings indicate that it is an intrinsic property of
FOXO1 and its apparent acetylation status that modulate
FOXO1 phosphorylation and adipocyte differentiation. Inetabolism 6, 105–114, August 2007 ª2007 Elsevier Inc. 111
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acetylation can affect its DNA binding activity. It is possi-
ble that the effects of foxo1mutants on adipocyte differen-
tiation are mediated by similar changes. Combining these
data with previous studies indicating that Sirt1 can also
deacetylate FOXO1, it is possible that SIRT2 may target
FOXO1 in the cytoplasm, while Sirt1 catalyzes FOXO1 de-
acetylation in the nucleus. It is also possible these two
proteins recruit different cofactors and have different
physiological or pathological regulation, allowing them to
carry out distinctive functions on the target. It is not known
if there is any specificity of SIRT2 in deacetylation of spe-
cific Lys residues of the FOXO1 protein. It would also be of
interest to compare the enzymatic activity of SIRT1 and
SIRT2 on each potential acetylation site to further deter-
mine their relative roles on FOXO1.
While the current data support an important role of sirt2
in adipocyte differentiation, how sirt2 acts on this process
in normal physiology needs further study. Since many of
the Class III HDACs of the sirtuin family require NAD as
a cofactor, it is quite possible that, in addition to the level
of expression, one potential regulator of the activity of
sirt2 in normal cells is the level of NAD. This would allow
sirt2 to serve as a sensor of the cellular redox state and
nutrient input with the ability to regulate gene expression
and metabolism. It will be interesting to determine if
SIRT2 can interact with FOXO1 in other tissues, such as
liver, where foxo1 has an important role in control of gluco-
neogenesis, and its response to nutrient input and stress
conditions.
Transcriptional activation and repression in eukaryotic
cells has been shown to be involved closely with protein
acetylation/deacetylation mediated by histone acetyl-
transferases (HATs) and histone deacetylases (HDACs).
The reversible acetyl-modification on Lys residues of tran-
scription factors provides a mechanism by which modu-
lating activities of either HATs or HDACs leads to changes
in the expression of genes in metabolic pathways. This
process could be further modulated by nutritional and
redox state.
sirt2, like sirt1, is ubiquitously expressed, suggesting
important functions in many types of cells. Undoubtedly,
more sirt2 targets await identification. It seems likely that
sirt2 will regulate other transcription factors besides
foxo1. By analogy with foxo1, the acetylation/deacetyla-
tion of these factors may promote or antagonize their
ability to undergo phosphorylation and regulate transcrip-
tion. Drugs that activate or inhibit sirt2 could regulate the
acetylation state of FOXO1 and likely other transcription
factors, thereby potentially regulating a wide variety of bi-
ological events. sirt2 may serve as the key regulator for
multiple targets, most of which are yet to be discovered.
EXPERIMENTAL PROCEDURES
Cell Culture and Adipocyte Differentiation
HEK293 cells and 3T3-L1 (American Type Culture Collection, ATCC,
Manassas, VA) preadipocytes were cultured in high-glucose
(400 mg/dl) Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen)112 Cell Metabolism 6, 105–114, August 2007 ª2007 Elsevier Incontaining 10% fetal bovine serum (FBS; Gemini Bioproducts). 3T3-L1
cells, including different stable transfected cell lines used for differen-
tiation, were maintained in 10% FBS DMEM with high glucose. Differ-
entiation was induced 2 days after the cells reached confluence (day 0)
by adding an induction cocktail containing 100 nM insulin (Sigma),
1 mM dexamethasone (Dex; Sigma-Aldrich), and 0.5 mM 1-methyl-3-
isobutyl-xanthine (IBMX; Sigma-Aldrich) to the medium containing
10% FBS. After 2 additional days (day 2), the medium was replaced
by DMEM 10% FBS containing 100 nM insulin, and then media were
changed every 2 days until the cells became mature adipocytes
(day 10). All cells were maintained and differentiated at 37C in an
environment with 5% CO2.
Plasmids and Constructs
For overexpression, a SIRT 2-FLAG andSIRT2-HA construct were pre-
pared using sirt2 cDNA derived from 3T3-L1 total cDNA produced by
reverse transcription polymerase chain reaction and were inserted into
pBabe-Bleo retroviral vector (Wei et al., 2003). Sirt2 shRNAs were de-
signed using the Dhamarconwebsite. Oligos containing sense and an-
tisense siRNA sequence with separating loop region were synthesized
by IDTDNA Technology, Inc. Oligo pairs were annealed in a buffer con-
taining 100mMTris HCL (pH 7.5), 1MNaCl, and 10mMEDTA and then
inserted into HindIII-BglII sites of pSuper-Retro vector (McIntyre and
Fanning, 2006; Taxman et al., 2006). Oligonucleotide sequences are
shown in Table S1.
The FLAG-tagged wild-type foxO1, KQ (Lys residues converted to
Glx) and KR (Lys residues converted to Arg) mutants cDNA were gifts
from Dr. Akiyoshi Fukamizu of University of Tsukuba, Japan. Con-
structs of foxo1 wild-type and mutants for overexpression were sub-
cloned into pBabe bleo retroviral vectors.
Immunoprecipitation and Western Blot Analysis
For immunoprecipitation experiments, cells were grown to confluence,
nondenaturing cell lysates were prepared, and immunoprecipitation
was done as previously described (Entingh et al., 2003).
Western blot experiments were done after treatment and sample
collection. Cell lysate was fractionated by SDS-10% polyacrylamide
gel electrophoresis and transferred to PVDF membranes (Amersham).
After blocking with recommended blocking reagents for 1 hr at room
temperature, the membranes were incubated overnight at 4C with
different antibodies. Antibodies used for western blot and IP are shown
in Table S2. The membranes were incubated with 1:2000–1:10000
secondary antibodies conjugated with HRP for 1 hr at room tempera-
ture after washing 33 for 10 min each. Signals were detected by using
the Amersham ECL chemiluminescence system and visualized by
autoradiography.
Retroviral Infection and Transient Transfection
Retroviruses were produced as previously described (Entingh et al.,
2003). Stable retroviral transduction of 3T3-L1 cells was achieved by
infection for 12–16 hr. The cells were plated into 30 cm diameter Petri
dishes and grown for 48–72 hr, after which selection with either Puro-
mycin (2 mg/ml) or Zeocin (250 mg/ml) was initiated. Selection was
stopped as soon as the noninfected control cell died off, and themedia
were replaced with normal-growing media. The efficacy of overex-
pression was determined by western blot. The efficacy of knockdown
at the protein level was assessed using both western blots.
The cotransfection for recombinant SIRT2-HA and FOXO1-FLAG
was done in HEK293 cells using Lipofectamine2000 (Invitrogen).
Immunocytochemistry
After being grown on coverslips for 48 hr in 10% FBS DMEM media,
cells were fixed with 10% formalin, washed 33with PBS, then perme-
ablized with 1% Triton X-100 and 1% BSA in PBS. After washing 33,
fixed cells were blocked with 10% goat serum and 1% BSA for 1 hr,
then incubated with FLAG-conjugate antibody in 1% BSA for 1–2 hr.
Signal was detected using GFP fluorescent microscope.c.
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RNA samples were extracted using RNeasy kit (QIAGEN). Each condi-
tion was performed in triplicate to allow for statistical analysis. The
cDNA was synthesized using 1 mg total RNA using All Advantage
RT-PCR kit. For quantification of relative expression levels of different
Sirt mRNAs, 5 ml of cDNA were used for each reaction. To quantify the
molar amount of RNA present in the samples, the end product of real-
time PCR for different Sirt genes was purified with PCR MiniElute kit
(QIAGEN), then quantified with NanoDrop 1000 and serially diluted
10-fold for each product; quantitative real-time PCR was performed
using diluted PCR products with corresponding primers, Ct values of
different dilutions were obtained, and linear regression graphs were
created for each gene with absolute units derived from Ct values
and with a corresponding molar amount based on PCR sizes. The cor-
responding target transcript molar amount used in quantitative real-
time PCR was accessed from the linear regression, then the molar
amount of each gene per microgram total RNA was calculated based
on total cDNA synthesis reaction volume and cDNA volume used for
real-time PCR. For the differentiation time course experiments, real-
time PCR was performed with 5 ml of cDNA using Sybrgreen master
mix (Applied Biosystems) on ABI 7000 thermal cycler, and dCt values
were collected by using either 18S ribosomal RNA or TATA-box bind-
ing protein (TBP) to normalize expression. The dCt values were calcu-
lated using absolute Ct values of the normalizer subtracted by Ct
values of target genes. Final values were calculated using 2 exponen-
tial to the dCt. Student’s t test was performed between two different
cell lines, and significance was achieved when p < 0.05. The standard
errors (SEs) for individual quantifications are presented as error bars
for all the real-time PCR data graphs. Primers for real-time PCR using
Sybrgreen are shown in Table S3.
Supplemental Data
Supplemental Data include three tables and five figures and can be
found with this article online at http://www.cellmetabolism.org/cgi/
content/full/6/2/105/DC1/.
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